etoposide and cisplatin
Randomized phase III study comparing etoposide and cisplatin (EP) with irinotecan and cisplatin (IP) following accelerated hyperfractionated thoracic radiotherapy (EP/AHTRT) for the treatment of limited-stage small-cell lung cancer (LD-SCLC): JCOG0202.
Randomized phase III study comparing etoposide and cisplatin ( EP ) with irinotecan and cisplatin ( IP ) following accelerated hyperfractionated thoracic radiotherapy ( EP / AHTRT ) for the treatment of limited-stage small-cell lung cancer ( LD-SCLC ) : JCOG0202 .